Skip to main content

Berta Ferrer Fábrega

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Berta Ferrer Fábrega

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Projects

Tumor dependent immune evasive mechanisms in melanoma

IP: Juan Angel Recio Conde
Collaborators: Paula Granado Martinez, Kimberley Anne McGrail Fernández, Vicente García-Patos Briones, Berta Ferrer Fábrega, Eva Muñoz Couselo, Yuxin Ding , Roberto Orsenigo
Funding agency: Instituto de Salud Carlos III
Funding: 321250
Reference: PI23/00428
Duration: 01/01/2024 - 31/12/2026

Novel therapeutic topical approach for discoid lupus cutaneous (DLE) treatment

IP: Cristina Solé Marce
Collaborators: Berta Ferrer Fábrega, Gloria Aparicio Español
Funding agency: Instituto de Salud Carlos III
Funding: 99099
Reference: PI21/01869
Duration: 01/01/2022 - 31/12/2025

Oncogene-mediated intratumoral immune-cell populations at different organs as biomarkers of immunotherapy response

IP: Juan Angel Recio Conde
Collaborators: Paula Granado Martinez, Kimberley Anne McGrail Fernández, Vicente García-Patos Briones, Berta Ferrer Fábrega, Sara Garcia Ortega, Eva Muñoz Couselo
Funding agency: Instituto de Salud Carlos III
Funding: 341220
Reference: PI20/00384
Duration: 01/01/2021 - 30/04/2024

Modulation of melanoma-stroma interactions using a rationally-designed nanomedicine combining BRAFi-, MEKi- and immunetherapies

IP: Juan Angel Recio Conde
Collaborators: Berta Ferrer Fábrega, Eva Muñoz Couselo
Funding agency: Instituto de Salud Carlos III
Funding: 96072.79
Reference: AC16/00019
Duration: 01/01/2017 - 31/12/2019

Related news

The findings pave the way for the development of new therapeutic strategies combining immunotherapy with p38α protein inhibitors.

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The study reveals that if the exposure of newborns to solar radiation of sufficient intensity to provoke a skin reaction is simultaneous with the activation of the BRAFv600E gene, it can trigger an uncontrolled proliferation of cancer cells.

Related professionals

Alba Jané Dern

Alba Jané Dern

Gestió i Administració
Communication Unit
Communication Directorate
Read more
Guillem Sarró Cardelús

Guillem Sarró Cardelús

Gestió i Administració
Unidad de Proyectos Post-Award
Competitive Research Directorate
Read more
Sara Marmolejo Martinez

Sara Marmolejo Martinez

Postdoctoral researcher
Peripheral Nervous System
Read more
Vanessa Reig Sorribes

Vanessa Reig Sorribes

Gestió i Administració
Commercial and Academic Clinical Research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.